FRX Forest Road Acquisition Corp

Synergy Pharmaceuticals, Inc. (SGYP) was a big mover last session, as the company saw its shares rise nearly 9% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock has risen about 12% since Dec 11.

Over the last 30 days, Synergy Pharmaceuticals did not witness any estimate revision and the Zacks Consensus Estimate has remained unchanged. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Synergy Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Heska Corporation (HSKY), Questcor Pharmaceuticals, Inc. (QCOR) and Forest Laboratories Inc. (FRX), each with a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




 
FOREST LABS A (FRX): Free Stock Analysis Report
 
HESKA CORP (HSKA): Free Stock Analysis Report
 
QUESTCOR PHARMA (QCOR): Free Stock Analysis Report
 
SYNERGY PHARMAC (SGYP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research